topics biopharmaceutical 
Herbert Smith Freehills
JUNE 11, 2023
Cutia Therapeutics is an R&D-driven, dermatology-focused biopharmaceutical company. The company focuses on broader dermatology treatment and care therapeutic areas, including localised adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia.
LexBlog IP
SEPTEMBER 24, 2022
The NSF funding Regional Innovation Engines to support biotechnology and biomanufacturing topics such as manufacturing life-saving medicines.
Fish & Richardson Trademark & Copyright Thoughts
JANUARY 11, 2022
The letter discusses the BPCIA and the Hatch-Waxman Act frameworks (for small molecule drugs) and sets forth several topics for USPTO’s consideration and further discussion: engagement between FDA and USPTO to increase efficiencies, possible misuse of the patent system (e.g., In Ipsen Biopharmaceuticals, Inc. 1 at ¶¶ 20–21.)
Expert insights. Personalized for you.
52 
Let's personalize your content